WASHINGTON, D.C. — Following scientific review by the U.S. Food and Drug Administration (FDA), the agency issued a renewal of ...

CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

The partnership with Telix, which covers North America and the European Union (EU, excluding France and French speaking Belgium), launches in the United States (U.S.) with Illuccix, with the aim to ...

Forest Dogs will expand its business on a former equestrian site in Sheffield Plans for a dog day care business to operate in a field near the Peak District National Park have been approved.

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration ... This is the first approved indication for Orlynvah and Iterum's first FDA-approved product.

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year. The Food and Drug Administration ... When a drug sponsor proposes that the FDA ...

On October 1, 2024, the US Food and Drug Administration (FDA) announced the implementation of its long-promised reorganization, with the establishment of the unified Human Foods Program (HFP).

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer. Marketed under the brand name Vyloy, the drug is to ...

According to the release, the United States Food and Drug Administration ... However there is currently no FDA-approved ...